• SENSEX 72,480.29
    -48.78 (--0.07%)
  • BANKNIFTY 54,633.05
    373.10 (+0.69%)
  • Avalon Tech
    2,171.00 778.15(%)
  • Bharti Airtel
    1,753.30 1,745.00(%)
  • NSE
    1,761.00 1,761.00(%)
  • Molbio Diagnosti
    1,368.00 1,686.50(%)
  • Apollo Hospitals
    8,063.00 6,680.00(%)
  • Innova Captab
    1,080.00 608.25(%)
  • Hero Motors
    152.58 156.03(%)
  • Meesho
    230.55 254.65(%)
  • Azad Engineering
    3,126.00 3,126.00(%)
  • Shadowfax Technologies
    278.10 98.60(%)
  • Cupid
    312.10 312.10(%)
  • L&T Finance Ltd
    264.75 234.90(%)
  • Lenskart Solut.
    698.00 725.00(%)
  • Reliance Industries
    1,196.30 1,611.20(%)
  • SS Retail
    761.45 888.00(%)
  • Sun TV Network
    664.60 664.60(%)
  • Solar Industries
    19,820.00 22,630.05(%)
  • PB Fintech.
    1,040.00 1,040.00(%)
  • National High
    168.00 142.00(%)
  • HDFC Bank
    709.70 682.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7690.0
  • ISIN : INE858L01010
74.53 -4 (-4.77%)
  • As on 30 Sep 2026 (EOD)

  • Today’s Low

    74.00

  • Today’s High

    80.00

  • Open

    80.00

  • Perv Close

    78.26

  • 52W Low

    61.00

  • 52W High

    92.52

Key Indicators

  • P/E(TTM)

    48.08

  • Mar.Cap (₹Cr.)

    98.19

  • Div & Yield %

    0.00

  • Book Value(₹)

    35.43

  • Debt-Equity Ratio

    -4.77

  • AGM Date

    30-Sep-2026

  • EPS

    1.55

  • P/E Ratio

    48.08

Financials Ratios

  • Debt-Equity Ratio

    0.53

  • Mar.Cap (₹Cr.)

    98.19

  • RONW (%)

    1.43

  • ROCE (%)

    4.75

Score Board

  • Equity (₹ in Cr.)

    13.18

  • BV (₹)

    35.40

  • Sales( ₹ in Cr.)

    75.85

  • NP (in Cr.)

    1.04

  • NP Var(%)

    251.0

  • Div%

    0.0

  • CPS (₹)

    1.80

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    98.19

  • 52 Week High

    92.52

  • 52 Week Low

    61.00

  • Price BSE

    75.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    98.19

  • P/C Ratio

    41.30

  • P/E Ratio

    95.30

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 75.85 36.93 43.26 51.31 58.96 51.36
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.85 36.93 43.26 51.31 58.96 51.36
Other Income 0.03 0.01 0.01 0.01 0.10 3.86
Stock Adjustments -1.69 1.14 0.40 -0.52 2.31 -1.69
Total Income 74.19 38.08 43.67 50.80 61.37 53.53
EXPENDITURE :            
Raw Materials 63.45 28.78 33.71 40.36 44.41 41.28
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 3.82 3.31 3.87 3.55 4.14 3.47
Other Manufacturing Expenses 0.56 0.34 0.39 0.44 0.43 0.60
Selling and Administration Expenses 1.98 1.81 1.95 2.05 1.52 1.03
Miscellaneous Expenses 0.12 0.06 0.07 0.06 5.19 0.07
Employee Benefit Expenses 3.82 3.31 3.87 3.55 4.14 3.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 69.93 34.30 39.99 46.46 55.67 46.45
Operating Profit 4.27 3.78 3.69 4.35 5.69 7.08
Interest 1.46 1.72 1.59 1.62 1.68 1.42
Gross Profit 2.81 2.06 2.10 2.73 4.01 5.66
Depreciation 1.36 1.42 1.54 1.60 1.76 1.37
Profit Before Tax 1.45 0.64 0.56 1.13 2.25 4.29
Current Tax 0.41 0.19 0.20 0.35 0.67 0.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.16 -0.06 -0.11 -0.02 0.54
Reported Net Profit 1.04 0.30 0.42 0.89 1.59 3.28
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 2.88
Adjusted Net Profit 1.04 0.30 0.42 0.89 1.59 0.40
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.01 0.00
P & L Balance brought forward 15.11 14.82 14.40 13.51 11.91 8.63
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 16.15 15.11 14.82 14.40 13.51 11.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.79 0.30 0.42 0.96 1.82 3.75
Earnings Per Share(Adj)-Unit Curr 0.79 0.30 0.42 0.96 1.82 3.75
Book Value 35.43 34.11 33.82 33.43 32.44 30.61
Book Value(Adj)-Unit Curr 35.43 34.11 33.82 33.43 32.44 30.61

Shareholding Pattern

  • Promoter Group

    45.08%

  • Public Share Holding

    54.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,939,204 45.08 5,939,204 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,939,204 45.08 5,939,204 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 81,851 0.62 81,851 9
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 13,462 0.10 13,462 24
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,631,238 35.15 4,631,238 37
Individuals holding nominal share capital up to Rs. 1 lakh 2,508,245 19.04 2,015,295 4,361
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.01 1,000 1
Others 0 0.00 0 0
Sub Total 7,235,796 54.92 6,742,846 4,432
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,175,000 100.00 12,682,050 4,435

Company Background

Concord Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Drugs Ltd
  • BSE Code : 7690.0
  • ISIN : INE858L01010

  • Incorporation Year

    1995

  • Registered Office

    Survey No 249 Brahmanapally V
    Hayathnagar M, Ranga Reddy,
    Telangana-501511

  • Telephone

    91-40-24036379

  • FAX

  • Chairman

    S Nagi Reddy

  • Managing Director

  • Company Secretary

    Namratha

  • Auditor

    Pundarikashyam and Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Concord Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Drugs 74.53 75.88 75.85 48.08 4.94
Abbott India 27,149.40 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,188.75 2,304.07 2,275.58 91.21 27.86
Glaxosmi. Pharma 2,767.60 3,932.76 3,790.20 44.21 58.17
Novartis India 1,923.85 393.10 354.33 48.58 15.94
Cipla 1,350.00 20,102.60 18,979.95 35.48 13.88
Bliss GVS Pharma 695.35 773.53 729.81 64.62 12.51
Fermenta Biotec. 549.65 474.15 450.25 25.66 18.77
Amrutanjan Healt 514.30 520.13 502.55 27.55 24.16
Guj. Themis Bio. 387.75 168.25 165.82 103.68 18.05
Ambalal Sarabhai 39.51 19.52 3.94 73.17 6.77